$32MSeries D, 25 August 2025
Funds commercialisation and gives runway into H2 2027; equity portion stated separately from a A$40M debt facility.
- Amount
- $32M
- Stage
- Series D
- Announced
- 25 August 2025
- Lead
- SPRIM Global Investments
- Other investors
- LGT Crestone, OneVentures, Brandon Capital
- Use of funds
- Funds commercialisation and gives runway into H2 2027; equity portion stated separately from a A$40M debt facility.
- Checked
- Announced by the company
- Sources
- Vaxxas raises A$49.2M equity (A$90M incl. debt) Series D biospace.com
Vaxxas raises A$49.2M equity (A$90M incl. debt) Series D techstartups.com